Evaluation of the Concurrent Trajectories of Cardiometabolic Risk Factors in the 14 Years before Dementia

JAMA Psychiatry

Volumn 75, Issue 10, 2018, Pages 1033-1042

  Wagner, Maude ^a   Helmer, Catherine ^a   Tzourio, Christophe ^a   Berr, Claudine ^b   Proust Lima, Cécile ^a   Samieri, Cécilia ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b INSERM U1061   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGED; BLOOD; BLOOD PRESSURE; BODY MASS; CASE CONTROL STUDY; COHORT ANALYSIS; DEMENTIA; FEMALE; FRANCE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOTENSION; INCIDENCE; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PRODROMAL SYMPTOM; RISK FACTOR; TIME FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COHORT STUDIES; DEMENTIA; FEMALE; FRANCE; HUMANS; HYPERGLYCEMIA; HYPOTENSION; INCIDENCE; MALE; PRODROMAL SYMPTOMS; RISK FACTORS; TIME FACTORS; TRIGLYCERIDES;

EID: 85054451427     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2018.2004     Document Type: Article

References (64)

1. Breteler MM. Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol Aging. 2000; 21 (2): 153-160. doi: 10.1016/S0197-4580(99)00110-4 10867200
2. Stampfer MJ. Cardiovascular disease and Alzheimer's disease: common links. J Intern Med. 2006; 260 (3): 211-223. doi: 10.1111/j.1365-2796.2006.01687.x 16918818
3. Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C. Potential for primary prevention of Alzheimer's disease: an analysis of population-based data. Lancet Neurol. 2014; 13 (8): 788-794. doi: 10.1016/S1474-4422(14)70136-X 25030513
4. Winblad B, Amouyel P, Andrieu S, Defeating Alzheimer's disease and other dementias: a priority for European science and society. Lancet Neurol. 2016; 15 (5): 455-532. doi: 10.1016/S1474-4422(16)00062-4 26987701
5. Tolppanen AM, Ngandu T, Kåreholt I, Midlife and late-life body mass index and late-life dementia: results from a prospective population-based cohort. J Alzheimers Dis. 2014; 38 (1): 201-209. doi: 10.3233/JAD-130698 23948937
6. Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP Jr, Yaffe K. Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ. 2005; 330 (7504): 1360. doi: 10.1136/bmj.38446.466238.E0 15863436
7. Kivipelto M, Helkala EL, Laakso MP, Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ. 2001; 322 (7300): 1447-1451. doi: 10.1136/bmj.322.7300.1447 11408299
8. Anstey KJ, Ashby-Mitchell K, Peters R. Updating the evidence on the association between serum cholesterol and risk of late-life dementia: review and meta-analysis. J Alzheimers Dis. 2017; 56 (1): 215-228. doi: 10.3233/JAD-160826 27911314
9. Solomon A, Kivipelto M, Wolozin B, Zhou J, Whitmer RA. Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later. Dement Geriatr Cogn Disord. 2009; 28 (1): 75-80. doi: 10.1159/000231980 19648749
10. Tuligenga RH, Dugravot A, Tabák AG, Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study. Lancet Diabetes Endocrinol. 2014; 2 (3): 228-235. doi: 10.1016/S2213-8587(13)70192-X 24622753
11. Launer LJ, Ross GW, Petrovitch H, Midlife blood pressure and dementia: the Honolulu-Asia Aging Study. Neurobiol Aging. 2000; 21 (1): 49-55. doi: 10.1016/S0197-4580(00)00096-8 10794848
12. Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology. 2005; 64 (2): 277-281. doi: 10.1212/01.WNL.0000149519.47454.F2 15668425
13. Qizilbash N, Gregson J, Johnson ME, BMI and risk of dementia in two million people over two decades: a retrospective cohort study. Lancet Diabetes Endocrinol. 2015; 3 (6): 431-436. doi: 10.1016/S2213-8587(15)00033-9 25866264
14. Gottesman RF, Albert MS, Alonso A, Associations between midlife vascular risk factors and 25-year incident dementia in the Atherosclerosis Risk in Communities (ARIC) cohort. JAMA Neurol. 2017; 74 (10): 1246-1254. doi: 10.1001/jamaneurol.2017.1658 28783817
15. Fitzpatrick AL, Kuller LH, Lopez OL, Midlife and late-life obesity and the risk of dementia: Cardiovascular Health Study. Arch Neurol. 2009; 66 (3): 336-342. doi: 10.1001/archneurol.2008.582 19273752
16. Anstey KJ, Cherbuin N, Budge M, Young J. Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies. Obes Rev. 2011; 12 (5): e426-e437. doi: 10.1111/j.1467-789X.2010.00825.x 21348917
17. Gottesman RF, Schneider ALC, Zhou Y, Association between midlife vascular risk factors and estimated brain amyloid deposition. JAMA. 2017; 317 (14): 1443-1450. doi: 10.1001/jama.2017.3090 28399252
18. Qiu C, von Strauss E, Fastbom J, Winblad B, Fratiglioni L. Low blood pressure and risk of dementia in the Kungsholmen Project: a 6-year follow-up study. Arch Neurol. 2003; 60 (2): 223-228. doi: 10.1001/archneur.60.2.223 12580707
19. Skoog I, Lernfelt B, Landahl S, 15-year longitudinal study of blood pressure and dementia. Lancet. 1996; 347 (9009): 1141-1145. doi: 10.1016/S0140-6736(96)90608-X 8609748
20. Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I. An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med. 2003; 163 (13): 1524-1528. doi: 10.1001/archinte.163.13.1524 12860573
21. Crane PK, Walker R, Hubbard RA, Glucose levels and risk of dementia. N Engl J Med. 2013; 369 (6): 540-548. doi: 10.1056/NEJMoa1215740 23924004
22. Xu W, Qiu C, Gatz M, Pedersen NL, Johansson B, Fratiglioni L. Mid- and late-life diabetes in relation to the risk of dementia: a population-based twin study. Diabetes. 2009; 58 (1): 71-77. doi: 10.2337/db08-0586 18952836
23. Cheng G, Huang C, Deng H, Wang H. Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J. 2012; 42 (5): 484-491. doi: 10.1111/j.1445-5994.2012.02758.x 22372522
24. Singh-Manoux A, Dugravot A, Shipley M, Obesity trajectories and risk of dementia: 28 years of follow-up in the Whitehall II Study. Alzheimers Dement. 2018; 14 (2): 178-186. doi: 10.1016/j.jalz.2017.06.2637 28943197
25. Sabia S, Dugravot A, Dartigues JF, Physical activity, cognitive decline, and risk of dementia: 28 year follow-up of Whitehall II cohort study. BMJ. 2017; 357: j2709. doi: 10.1136/bmj.j2709 28642251
26. Amieva H, Le Goff M, Millet X, Prodromal Alzheimer's disease: successive emergence of the clinical symptoms. Ann Neurol. 2008; 64 (5): 492-498. doi: 10.1002/ana.21509 19067364
27. Singh-Manoux A, Dugravot A, Fournier A, Trajectories of depressive symptoms before diagnosis of dementia: a 28-year follow-up study. JAMA Psychiatry. 2017; 74 (7): 712-718. doi: 10.1001/jamapsychiatry.2017.0660 28514478
28. Power MC, Weuve J, Gagne JJ, McQueen MB, Viswanathan A, Blacker D. The association between blood pressure and incident Alzheimer disease: a systematic review and meta-analysis. Epidemiology. 2011; 22 (5): 646-659. doi: 10.1097/EDE.0b013e31822708b5 21705906
29. 3C Study Group. Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population. Neuroepidemiology. 2003; 22 (6): 316-325. doi: 10.1159/000072920 14598854
30. World Health Organization. Guidelines for ATC Classification and DDD Assignment. Oslo, Norway: Norwegian Institute of Public Health; 2002.
31. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984; 34 (7): 939-944. doi: 10.1212/WNL.34.7.939 6610841
32. Robins JM, Gail MH, Lubin JH. More on "biased selection of controls for case-control analyses of cohort studies." Biometrics. 1986; 42 (2): 293-299. doi: 10.2307/2531050 3741971
33. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18 (6): 499-502. 4337382
34. Proust-Lima C, Amieva H, Jacqmin-Gadda H. Analysis of multivariate mixed longitudinal data: a flexible latent process approach. Br J Math Stat Psychol. 2013; 66 (3): 470-487. 23082854
35. Bergstralh E, Kosanke J. Computerized matching of controls. In: Technical Report Series, Number 56. Rochester, MN: Mayo Clinic Department of Health Sciences Research; 1995.
36. Proust-Lima C, Philipps V, Liquet B. Estimation of extended mixed models using latent classes and latent processes: the R package lcmm. J Stat Softw. 2017; 78 (2): 1-56. doi: 10.18637/jss.v078.i02
37. Ferrara A, Barrett-Connor E, Shan J. Total, LDL, and HDL cholesterol decrease with age in older men and women: the Rancho Bernardo Study 1984-1994. Circulation. 1997; 96 (1): 37-43. doi: 10.1161/01.CIR.96.1.37 9236414
38. Wilson PW, Anderson KM, Harris T, Kannel WB, Castelli WP. Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. J Gerontol. 1994; 49 (6): M252-M257. doi: 10.1093/geronj/49.6.M252 7963277
39. Loh TP, Ma S, Heng D, Khoo CM. Age-related changes in the cardiometabolic profiles in Singapore resident adult population: findings from the National Health Survey 2010. PLoS One. 2016; 11 (8): e0162102. doi: 10.1371/journal.pone.0162102 27570971
40. Franklin SS, Gustin W IV, Wong ND, Hemodynamic patterns of age-related changes in blood pressure: the Framingham Heart Study. Circulation. 1997; 96 (1): 308-315. doi: 10.1161/01.CIR.96.1.308 9236450
41. van Popele NM, Grobbee DE, Bots ML, Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke. 2001; 32 (2): 454-460. doi: 10.1161/01.STR.32.2.454 11157182
42. Bots ML, Witteman JC, Hofman A, de Jong PT, Grobbee DE. Low diastolic blood pressure and atherosclerosis in elderly subjects: the Rotterdam Study. Arch Intern Med. 1996; 156 (8): 843-848. doi: 10.1001/archinte.1996.00440080029004 8774202
43. Menke A, Rust KF, Savage PJ, Cowie CC. Hemoglobin A1c, fasting plasma glucose, and 2-hour plasma glucose distributions in US population subgroups: NHANES 2005-2010. Ann Epidemiol. 2014; 24 (2): 83-89. doi: 10.1016/j.annepidem.2013.10.008 24246264
44. Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol. 2005; 4 (8): 487-499. doi: 10.1016/S1474-4422(05)70141-1 16033691
45. Szoke E, Shrayyef MZ, Messing S, Effect of aging on glucose homeostasis: accelerated deterioration of beta-cell function in individuals with impaired glucose tolerance. Diabetes Care. 2008; 31 (3): 539-543. doi: 10.2337/dc07-1443 18083793
46. Johnson DK, Wilkins CH, Morris JC. Accelerated weight loss may precede diagnosis in Alzheimer disease. Arch Neurol. 2006; 63 (9): 1312-1317. doi: 10.1001/archneur.63.9.1312 16966511
47. Stewart R, Masaki K, Xue Q-L, A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study. Arch Neurol. 2005; 62 (1): 55-60. doi: 10.1001/archneur.62.1.55 15642850
48. Knopman DS, Edland SD, Cha RH, Petersen RC, Rocca WA. Incident dementia in women is preceded by weight loss by at least a decade. Neurology. 2007; 69 (8): 739-746. doi: 10.1212/01.wnl.0000267661.65586.33 17709705
49. Ogunniyi A, Gao S, Unverzagt FW, Weight loss and incident dementia in elderly Yoruba Nigerians: a 10-year follow-up study. Int Psychogeriatr. 2011; 23 (3): 387-394. doi: 10.1017/S1041610210001390 20735893
50. Barrett-Connor E, Edelstein SL, Corey-Bloom J, Wiederholt WC. Weight loss precedes dementia in community-dwelling older adults. J Am Geriatr Soc. 1996; 44 (10): 1147-1152. doi: 10.1111/j.1532-5415.1996.tb01362.x 8855991
51. McGrath ER, Beiser AS, DeCarli C, Blood pressure from mid- to late life and risk of incident dementia. Neurology. 2017; 89 (24): 2447-2454. doi: 10.1212/WNL.0000000000004741 29117954
52. Joas E, Bäckman K, Gustafson D, Blood pressure trajectories from midlife to late life in relation to dementia in women followed for 37 years. Hypertension. 2012; 59 (4): 796-801. doi: 10.1161/HYPERTENSIONAHA.111.182204 22331381
53. Stewart R, Xue Q-L, Masaki K, Change in blood pressure and incident dementia: a 32-year prospective study. Hypertension. 2009; 54 (2): 233-240. doi: 10.1161/HYPERTENSIONAHA.109.128744 19564551
54. Stewart R, White LR, Xue Q-L, Launer LJ. Twenty-six-year change in total cholesterol levels and incident dementia: the Honolulu-Asia Aging Study. Arch Neurol. 2007; 64 (1): 103-107. doi: 10.1001/archneur.64.1.103 17210816
55. Mielke MM, Zandi PP, Shao H, The 32-year relationship between cholesterol and dementia from midlife to late life. Neurology. 2010; 75 (21): 1888-1895. doi: 10.1212/WNL.0b013e3181feb2bf 21068429
56. Wilson RS, Arnold SE, Schneider JA, Tang Y, Bennett DA. The relationship between cerebral Alzheimer's disease pathology and odour identification in old age. J Neurol Neurosurg Psychiatry. 2007; 78 (1): 30-35. doi: 10.1136/jnnp.2006.099721 17012338
57. Wilson RS, Arnold SE, Schneider JA, Boyle PA, Buchman AS, Bennett DA. Olfactory impairment in presymptomatic Alzheimer's disease. Ann N Y Acad Sci. 2009; 1170: 730-735. doi: 10.1111/j.1749-6632.2009.04013.x 19686220
58. Pérès K, Helmer C, Amieva H, Natural history of decline in instrumental activities of daily living performance over the 10 years preceding the clinical diagnosis of dementia: a prospective population-based study. J Am Geriatr Soc. 2008; 56 (1): 37-44. doi: 10.1111/j.1532-5415.2007.01499.x 18028344
59. Tan ZS, Seshadri S, Beiser A, Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study. Arch Intern Med. 2003; 163 (9): 1053-1057. doi: 10.1001/archinte.163.9.1053 12742802
60. Burke WJ, Coronado PG, Schmitt CA, Gillespie KM, Chung HD. Blood pressure regulation in Alzheimer's disease. J Auton Nerv Syst. 1994; 48 (1): 65-71. doi: 10.1016/0165-1838(94)90160-0 8027519
61. Tzourio C, Laurent S, Debette S. Is hypertension associated with an accelerated aging of the brain? Hypertension. 2014; 63 (5): 894-903. doi: 10.1161/HYPERTENSIONAHA.113.00147 24566080
62. Strachan MWJ. R D Lawrence Lecture 2010: the brain as a target organ in type 2 diabetes: exploring the links with cognitive impairment and dementia. Diabet Med. 2011; 28 (2): 141-147. doi: 10.1111/j.1464-5491.2010.03199.x 21219420
63. Gustafson D. Adiposity indices and dementia. Lancet Neurol. 2006; 5 (8): 713-720. doi: 10.1016/S1474-4422(06)70526-9 16857578
64. Gelber RP, Gaziano JM, Orav EJ, Manson JE, Buring JE, Kurth T. Measures of obesity and cardiovascular risk among men and women. J Am Coll Cardiol. 2008; 52 (8): 605-615. doi: 10.1016/j.jacc.2008.03.066 18702962